Heart Failure Society Of America Recommends ICDs For Preventive Use
This article was originally published in The Gray Sheet
Executive Summary
New guidelines from the Heart Failure Society of America (HFSA) reinforce similar recommendations made by the American College of Cardiology and the American Heart Association to expand the preventive use of implantable cardioverter defibrillators (ICDs)
You may also be interested in...
ACA/AHA 2005 Guidelines Place Higher Emphasis On ICD, Resynchronization
The benefits of ICDs for patients with low ejection fraction are reinforced in 2005 ACC/AHA practice guidelines released Aug. 16
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.